COVID-19 treatments could be fast-tracked through new national clinical trial initiative

This platform will accelerate development of new drugs for patients hospitalised with COVID-19, reducing the time taken to set up clinical studies for new therapies. Six potential drugs will initially enter the programme, with the first of these beginning phase 2 studies.


Department of Health and Social Care